search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


21 resulaten gevonden voor Non small cell lung cancer (NSCLC) in trials

TKI concurrent with cerebral radiation therapy Dutch: TKI tegelijkertijd met bestraling van de hersenen
- TRIAL ID
NTR6707
- ACRONYMSATIN
The effect of the acid-reducing drug esomeprazol on afatinib in lung cancer patients
- TRIAL ID
NTR6652
- ACRONYMBIO-GIO study
CA209-762: Fine needle aspiration (EUS/EBUS) versus histology for PD-L1 staining in lung cancer
- TRIAL ID
NTR6217
- ACRONYMFNA versus histology
CA209-759: Blood-borne biomarkers for tumor response to Nivolumab in KRAS-mutated non-small cell lung cancer
- TRIAL ID
NTR6158
- ACRONYMBiomarkers for tumor response to PD-1 inhibitors
Comparing tumour heterogeneity in primary tumour, circulating tumour cells and metastases
- TRIAL ID
NTR6042
- ACRONYMCTC Autopsy study
CEA als biomarker bij longcarcinoom
- TRIAL ID
NTR5921
- ACRONYMCEA
Treatment with BIBF1120 capsules lung carcinoma patients with an abnormal fibroblast growth factor-1 receptor (NVALT15)
- TRIAL ID
NTR4588
- ACRONYMNVALT15
Longitudinal analysis of lung cancer-specific immunity in stage III and IV non-small cell lung cancer patients.
- TRIAL ID
NTR3844
- ACRONYMTranslational research
Iressa RE-challenge in advanced NSCLC EGFR mutated patients who responded to an EGFR-TKI used as first-line or previous treatment - NVALT 16.
- TRIAL ID
NTR3792
- ACRONYMIRENE
Hoog-gedoseerde, pulsatiele erlotinib na progressie op standaard dosering erlotinib bij EGFR-gemuteerde NSCLC patienten.
- TRIAL ID
NTR3603
- ACRONYMPE study
FLT PET in patienten met niet kleincellig long carcinoom behandeld met gefitinib.
- TRIAL ID
NTR3557
- ACRONYM
Gefitinib and fulvestrant in patients with advanced, EGFR mutated NSCLC pretreated with EGFR TKI's.
- TRIAL ID
NTR3362
- ACRONYMGE study
Designing information for lung cancer patients in decision making.
- TRIAL ID
NTR3243
- ACRONYM
Fase II studie van sorafenib bij patienten met een gemetastaseerd niet-kleincellig bronchuscarcinoom die progressief zijn na voorafgaande behandeling met cisplatina bevattende chemotherapie waarvan de tumor een K-Ras mutatie bevat.
- TRIAL ID
NTR2530
- ACRONYM
Onderzoek naar de werkzaamheid van toevoeging van Cetuximab aan de combinatie van radiotherapie en Cisplatin bij patiŽnten met niet-kleincellig longkanker.
- TRIAL ID
NTR2230
- ACRONYMRADITUX
A phase 1 study with cisplatin and pemetrexed administered before or after stereotactic radiotherapy (SRT) in patients with stage IB non-small-cell lung cancer (NSCLC).
- TRIAL ID
NTR1824
- ACRONYMCisplatin-pemetrexed and SRT in stage IB NSCLC
Docetaxel and Carboplatin once every 3 weeks versus weekly Docetaxel in advanced non-small cell lung cancer: a Multicenter phase III study from the Dutch Chest Physician Association.
- TRIAL ID
NTR1627
- ACRONYMNVALT-1 study
Open label study to establish the efficacy of intravenous loading doses of Ibandronate 6 mg in patients with lung cancer and skeletal metastases experiencing moderate to severe bone pain: NVALT 9.
- TRIAL ID
NTR1602
- ACRONYMNVALT-9 study
Prophylactic Cranial Irradiation (PCI) versus observation in radically treated patients with stage III non-small cell lung cancer: A phase III randomized study.
- TRIAL ID
NTR1601
- ACRONYMNVALT-11 study/DLCRG-02 study
A randomized phase III study of adjuvant chemotherapy with or without low-molecular weight heparin in completely resected non-small-cell lung cancer patients with high-risk for recurrence: NVALT 8B
- TRIAL ID
NTR1250
- ACRONYMNVALT 8B
A randomized phase III study of adjuvant chemotherapy in patients with completely resected Non-Small-Cell Lung Cancer and low risk for recurrence
- TRIAL ID
NTR1217
- ACRONYMNVALT 8A